Inhibition of human P450 enzymes by nicotinic acid and nicotinamide-Reference-Cited by-同舟云学术

Inhibition of human P450 enzymes by nicotinic acid and nicotinamide

Published:2004-05 Issue:3 Volume:317 Page:950-956
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Gaudineau Cédric,Auclair Karine

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference19 articles.

1. Cytochrome P450: Structure, Mechanism, and Biochemistry;Ortiz de Montellano,1995

2. Mechanism of inhibition of adrenal steroid 11-beta-hydroxylase by methyrapone (metopirone);Dominguez;Endocrinology,1963

3. Inhibitors of cytochrome P450 and possibilities for their therapeutic application;Correia,1993

4. New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-substituted flavanone derivatives;Pouget;Bioorg. Med. Chem. Lett.,2002

5. Reconstructing eukaryotic NAD metabolism;Rongvaux;BioEssays,2003

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic transcript profiling in beef cattle: Effects of rumen-protected niacin supplementation;PLOS ONE;2023-08-03

2. COVID-19’s pandemic effects on smokers: A minireview;PROCEEDING OF THE 1ST INTERNATIONAL CONFERENCE ON ADVANCED RESEARCH IN PURE AND APPLIED SCIENCE (ICARPAS2021): Third Annual Conference of Al-Muthanna University/College of Science;2022

3. Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders;Current Neurovascular Research;2021-08-11

4. Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes;Current Neurovascular Research;2021-02-22

5. Sirtuins in metabolic disease: innovative therapeutic strategies with SIRT1, AMPK, mTOR, and nicotinamide;Sirtuin Biology in Cancer and Metabolic Disease;2021